Results 211 to 220 of about 68,956 (338)

A single HIIT session does not alter blood sphingolipid levels in healthy young adults: The SphingoHIIT randomized controlled trial. [PDF]

Comput Struct Biotechnol J
Angst T, Weber N, Fischer S, Lehmann J, Infanger D, Teav T, Schwendinger F, Streese L, Hinrichs T, Croci I, Schmied C, Gallart-Ayala H, Höchsmann C, Koehler K, Hanssen H, Schmidt-Trucksäss A, Ivanisevic J, Carrard J.   +17 more
europepmc   +1 more source

Modulation of human saposin B sphingolipid-binding specificity by alternative splicing. A study with saposin B-derived synthetic peptides.

, 1994
Sonia Lamontagne, Marie Potier‐Cartereau   +1 more
openalex   +1 more source

Skin Lipid–Microbe Interplay Links Staphylococcus hominis to Barrier Control in Adult Atopic Dermatitis

Allergy, EarlyView.
This study investigates mutual interaction of skin microbes and surface lipids in AD using the advanced method of shotgun lipidomics with ultra‐broad coverage of lipids and 16S amplicon sequencing of tape strips taken from lesional and non‐lesional AD and healthy controls.
Madhumita Bhattacharyya, Felix Lauffer, Manja Jargosch, Kristina Frey, Mahsa Shahidi Dadras, Theresa Raunegger, Sophia Wasserer, Carsten B. Schmidt‐Weber, Tilo Biedermann, Kilian Eyerich, Stefanie Eyerich, Claudia Traidl‐Hoffmann, Christian Klose, Matthias Reiger, Natalie Garzorz‐Stark   +14 more
wiley   +1 more source

The physiological and pathological effects of sphingolipid metabolism and signaling in the central nervous system

Brain Pathology, EarlyView.
Sphingolipids are vital components of cell membranes. Metabolic disruptions of sphingolipids, including ceramide and sphingosine‐1‐phosphate, are linked to neurological disorders. This article summarizes the classification, structure, and metabolic processes of sphingolipids, and the physiological and pathological effects of sphingolipid metabolism and
Tian Li, Haoying He, Ejuan Zhang, Fengjiao Hu, Zhuo Wang, Jian Xu, Mengliu Zeng, Biwen Peng   +7 more
wiley   +1 more source

Biosynthesis, Processing, and Targeting of Sphingolipid Activator Protein (SAP)Precursor in Cultured Human Fibroblasts [PDF]

, 1996
Gabriele Vielhaber, Robert Hurwitz, Konrad Sandhoff   +2 more
openalex   +1 more source

A Review Discussing Synthesis and Translational Studies of Medicinal Agents Targeting Sphingolipid Pathways. [PDF]

Biomolecules
Mateen S, Oman J, Haniyyah S, Sharma K, Aghazadeh-Habashi A, Pashikanti S.   +5 more
europepmc   +1 more source

Sphingosine-1-phosphate: a platelet-activating sphingolipid released from agonist-stimulated human platelets [PDF]

, 1995
Yutaka Yatomi, Fuqiang Ruan, S Hakomori, Yasushi Igarashi   +3 more
openalex   +1 more source

GPD1L‐Mediated Glycerophospholipid Metabolism Dysfunction in Women With Diminished Ovarian Reserve: Insights From Pseudotargeted Metabolomic Analysis of Follicular Fluid

Cell Proliferation, EarlyView.
Our study demonstrated the downregulation of GPD1L and its mediated glycerophospholipid metabolism dysfunction in patients with diminished ovarian reserve. Moreover, we verified that GPD1L knockdown leads to increased cell apoptosis and mitochondrial dysfunction of KGN cells, as well as impaired oocyte quality.
Jiaqi Wu, Xuehan Zhao, Ying Fang, Cong Wang, Yichang Tian, Wan Tu, Qiqian Wu, Long Yan, Xiaokui Yang   +8 more
wiley   +1 more source

Selective association of plasma sphingolipid species with insulin sensitivity and secretion in normoglycemic Black and White American adults. [PDF]

Exp Biol Med (Maywood)
Asuzu P, Feto NA, Wan J, Stentz F, Mandal N, Dagogo-Jack S.   +5 more
europepmc   +1 more source

Inhibition of sphingolipid induced apoptosis by caspase inhibitors indicates that sphingosine acts in an earlier part of the apoptotic pathway than ceramide [PDF]

, 1998
Elizabeth Sweeney, Jin‐ichi Inokuchi, Yasuyuki Igarashi   +2 more
openalex   +1 more source